Allevion Therapeutics Announces New Board Members and Successful Completion of Initial Pilot Clinical Study

Posted on March 17, 2022

IRVINE, Calif., March 15, 2022 /PRNewswire/ — Allevion Therapeutics announced today that the Medical and Scientific Advisory Board (SAB) is expanding to include three new members — Rajesh Pahwa, M.D., Stuart H. Isaacson, M.D., and Patrick McCartney. The expansion of the board coincides with the successful completion of an initial pilot clinical study.